Verification register Bio, Health & Neuro
Living definition
What is PEARL Rapamycin Longevity Trial?
Longevity & Aging Biotech Bio, Health & Neuro
- As of
- 2026-07-19
- Revision
- 2026-07-19.2
- Method
- v1.3.0
Definition
The term, in context
AI-assisted draft · approved dataset
The PEARL Rapamycin Longevity Trial is a clinical study testing whether low, intermittent doses of the drug rapamycin can slow measures of biological aging in healthy adults.
Live readiness status
Status as of the current dateline
AI-assisted assembly · derived results
As of 2026-07-19, verified readiness is 33 (claimed 45, reported 38, gap 12) — Strong evidence strength; current signals suggest Proceed with caution.
The readiness fact belongs to the canonical Readiness Verdict for PEARL Rapamycin Longevity Trial.
Dataset approval
Human editorial release
pragma.vision editorial — standing authorization (operator dev@soft.house, 2026-07-17)
- Dataset
- 2026-07-19.2
- Hash
- sha256:5b6f2a037b720dbb2ee4216d94ab16dcb623c06c65387010d64145dfda66d13d
- Approved
- 2026-07-19